Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion type Assertion NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_head.
- NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion description "[Autoantibodies directed against ion channels or associated proteins, such as K(+) channels, LGI1 or NMDA receptors, have been identified in epileptic disorders that can largely be included under the term limbic encephalitis which includes limbic seizures, status epilepticus and psychiatric symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_provenance.
- NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion evidence source_evidence_literature NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_provenance.
- NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion SIO_000772 23090947 NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_provenance.
- NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion wasDerivedFrom befree-20150227 NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_provenance.
- NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_assertion wasGeneratedBy ECO_0000203 NP817524.RARZgmeMoIp6cpHq2sXjgFc5J0J1KBZfgH1MYtRaeOWTI130_provenance.